Pharmacology News

Laws in 23 states that capped the number of days a Medicare enrollee could receive an initial opioid prescription may have had their intended effect, a recent study showed.

In a cohort of patients with COVID-19, along with those at high risk for COVID-19, CV drug use was not associated with poor clinical outcomes, researchers reported.

Therapeutic anticoagulation with heparin increased the likelihood of survival among noncritically ill patients who were hospitalized with COVID-19, according to a new study in The New England Journal of Medicine.

Adults with obesity participating in a real-world, employer-based weight-management program were significantly more likely to achieve clinically meaningful weight loss when adding pharmacotherapy to shared monthly visits, data show.

The CDC recently updated its guidance to say that even vaccinated individuals should wear masks indoors when in areas with high or substantial COVID-19 transmission.

Patients with untreated opioid use disorder responded well to a high-dose of buprenorphine in the ED.

The FDA has authorized emergency use of baricitinib alone for the treatment of adults and pediatric patients aged 2 years and older who are hospitalized with COVID-19.

The FDA approved the first interchangeable biosimilar insulin product to improve glycemic control for children and adults with diabetes, part of an effort to provide cost-effective options, according to an agency press release.

A 7-day course of ciprofloxacin or trimethoprim/sulfamethoxazole for presumed, symptomatic UTI in afebrile men was noninferior to 14 days of treatment, a randomized trial showed.

Angiotensin receptor blockers don’t significantly differ compared with ACE inhibitors as first-line treatment for patients with hypertension, but do present with a better safety profile, researchers reported.